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Abstract
The extracellular signal-regulated kinase (ERK) cascade has been shown to be a key modulator of
pain processing in the central nucleus of the amygdala (CeA) in mice. ERK is activated in the CeA
during persistent inflammatory pain and this activation is both necessary and sufficient to induce
peripheral tactile hypersensitivity. Interestingly, biochemical studies show that inflammationinduced ERK activation in the CeA only occurs in the right, but not the left hemisphere. This
inflammation-induced ERK activation in the right CeA is independent of the side of peripheral
inflammation, suggesting that there is a dominant role of the right hemisphere in the modulation of
pain by ERK activation in the CeA. However, the functional significance of this biochemical
lateralization has yet to be determined. In the present study, we tested the hypothesis that
modulation of pain by ERK signaling in the CeA is functionally lateralized. We acutely blocked ERK
activation in the CeA by infusing the MEK inhibitor U0126 into the right or the left hemisphere and
then measured the behavioral effects on inflammation-induced mechanical hypersensitivity in mice.
Our results show that blockade of ERK activation in the right, but not the left CeA, decreases
inflammation-induced peripheral hypersensitivity independent of the side of peripheral injury.
These findings demonstrate that modulation of pain by ERK signaling in the CeA is functionally
lateralized to the right hemisphere, suggesting a dominant role of the right amygdala in pain
processing.

Findings
The amygdala is a forebrain multinuclear structure with a
well-established role in emotional processing [1,2].
Increasing evidence supports the role of the central
nucleus of the amygdala (CeA) as a neural modulator of
pain perception [3]. Previous work from our laboratory
has identified the extracellular signal-regulated kinases
(ERKs) as key molecules for the modulation of pain by the
CeA in mice [4]. Biochemical experiments showed that
ERK is activated in the CeA during persistent inflamma-

tion. ERK activation in the CeA was shown to be necessary
for inflammation-induced peripheral hypersensitivity
because acute pharmacological blockade of ERK activation in this amygdala nucleus reduced inflammationinduced peripheral tactile hypersensitivity. Furthermore,
ERK activation in the amygdala was shown to be not only
necessary for inflammation-induced peripheral hypersensitivity but also sufficient to induce peripheral tactile
hypersensitivity in the absence of tissue injury.
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Interestingly, the biochemical data from our previous
study showed that inflammation-induced ERK activation
occurs in the right CeA independent of the side of peripheral inflammation (right or left hindpaw) [4]. These
results suggest that modulation of pain by ERK activation
in the CeA might be functionally lateralized to the right
hemisphere. We tested this hypothesis in the present
study by comparing the effects of acute blockade of ERK
activation in the right versus the left amygdala when
inflammation was induced in the right or the left hindpaw.
To induce peripheral inflammation in mice, a 5% formalin solution was injected subcutaneously into the right or
the left hind-paw as previously described [4]. Two hours
after formalin injection into the hind-paw, the MEK
inhibitor U0126 (1.5 nmoles), the inactive structural analog U0124 (1.5 nmoles) or vehicle (50% DMSO/Saline)
were infused into the right or the left CeA. Formalininduced mechanical sensitivity was measured 1 hr after
intra-amygdala drug infusion, which corresponds to 3 hrs
after formalin injection into the hind-paw. This timepoint was selected based on the results from our previous
study that show that ERK is activated in the CeA 3 hours
after formalin injection into the hind-paw [4]. At this
time-point we also observed significant formalin-induced
mechanical hypersensitivity, in both the injected and the
uninjured contralateral hind-paw [4].
In our previous study, we induced peripheral inflammation in the right hind-paw and performed the intra-amygdala drug infusions in the right amygdala. Under these
experimental conditions, blockade of ERK activation in
the right CeA significantly decreased formalin-induced
mechanical hypersensitivity, both in the injected paw and
in the uninjured contralateral paw, compared to animals
injected with vehicle or U0124 (Fig 1a) [4]. In the present
study, we tested whether ERK activation in the right CeA
modulates pain independently of the side of peripheral
inflammation by injecting formalin into the left hind-paw
and then infusing U0126, U0124 or vehicle into the right
CeA. Blinded behavioral analysis revealed that, similar to
our previous results in the right paw-injected mice, the left
paw-injected mice that received an infusion of U0126 into
the right CeA also exhibited significantly reduced formalin-induced mechanical hypersensitivity in both the
injected and the uninjured contralateral hind-paw (Fig
1b). Thus, mechanical thresholds in the injected paw of
U0126-infused mice were 0.63 g ± 0.12 (mean ± se;
approximately 47% of baseline); while vehicle- and
U0124-infused mice had mechanical thresholds of 0.10 g
± 0.02 and 0.16 g ± 0.00 (mean ± se; approximately 15%
of baseline) respectively. Similar effects on mechanical
thresholds were observed in the uninjured contralateral
hind-paw, with a mean threshold of 0.97 g ± 0.13 (mean
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± se; approximately 93% of baseline) in U0126-infused
mice and 0.47 g ± 0.04 (mean ± se; approximately 45% of
baseline) in both vehicle- and U0124-infused mice. Consistent with our previous study, intra-amygdala infusion
of the structural analog U0124 did not significantly affect
formalin-induced primary or secondary hypersensitivity
as mechanical thresholds in the injected and uninjured
contralateral hind-paw where not significantly different in
vehicle- and U0124-infused mice. The results from the
present study where we induce inflammation in the left
hind-paw, together with the results from our previous
work where we induced inflammation in the right hindpaw [4], show that inhibition of ERK activation in the
right CeA significantly reduces formalin-induced mechanical hypersensitivity independent of the side of peripheral
inflammation. These behavioral results nicely correlate
with our previous biochemical data that showed significant formalin-induced ERK activation in the right amygdala independent of the side of hind-paw injection [4].
Also consistent with our previous findings, mechanical
thresholds in the uninjured contralateral hind-paw of
U0126-infused mice were not significantly different from
pre-infusion baseline mechanical thresholds (1.03 ± 0.08;
mean ± se), suggesting that blockade of ERK activation in
the right CeA completely eliminates formalin-induced
secondary hypersensitivity.
Since the biochemical data from our previous work
showed a strong formalin-induced ERK activation in the
right, but not the left amygdala [4], we next asked whether
the effects of blockade of amygdala ERK activation are specific to the right amygdala or if inhibiting ERK activation
in the left amygdala would have similar behavioral effects.
To do this, we infused the MEK inhibitor U0126 or vehicle
into the left amygdala and then measured the effects on
formalin-induced mechanical hypersensitivity in both the
injected and the non-injured contralateral hind-paw.
Blockade of ERK activation in the left amygdala had no
significant effect on formalin-induced primary or secondary hypersensitivity whether formalin was injected into
the right or the left hind-paw (Fig 1c and 1d). These experiments demonstrate that modulation of pain perception
by amygdala ERK activation is preferentially mediated by
the right amygdala, suggesting a dominant role of the
right amygdala in pain processing.
Altogether, our results show a clear hemispheric lateralization of a central component of pain processing in the
amygdala of mice. Thus, blockade of ERK activation in the
right but not the left amygdala decreased inflammationinduced hypersensitivity independently of the side of
peripheral inflammation. Hemispheric lateralization of
amygdala function has been reported in humans and in
rodents [5-16]. Most of these studies measured neural
activity changes related to emotional memory and report
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Effects
Figureof1 intra-amygdala U0126 infusion on formalin-induced mechanical hypersensitivity
Effects of intra-amygdala U0126 infusion on formalin-induced mechanical hypersensitivity. Five days after cannulation, animals were injected with 5% formalin into the right (a, c) or the left (b, d) hind-paw. Two hours after the paw injection, mice were infused into the right (a, b) or the left (c, d) amygdala with the MEK inhibitor U0126 (n = 6 animals), the
structural analog control compound U0124 (n = 6 animals) or vehicle (n = 5–6 animals). One hour after the amygdala injection,
the effects of these treatments on mechanical thresholds were analyzed. U0126 infusion into the right amygdala significantly
reduced formalin-induced primary hypersensitivity and eliminated secondary hypersensitivity, independent of the side of paw
injection (p < 0.05, One-way ANOVA, Tukey's post-test; * = p < 0.05, *** = p < 0.0001) (a, b). U0126 infusion into the left
amygdala did not significantly affect formalin-induced mechanical hypersensitivity (c, d). Data displayed in panel A was obtained
with permission from Carrasquillo and Gereau, J Neurosci. 2007 Feb 14;27 (7): 1543–51.

differential activation of the left and the right amygdala in
humans during this process [5-10]. While there is no general agreement on the reasons for this lateralization, it has
been proposed to be dependent on the valence of the
stimulus (negative versus positive) [5]; on whether the
experience is conscious or unconscious [6]; learned
through anticipation or by actual experience [7]; or due to
gender differences [8-10]. Particularly relevant to our findings, fMRI studies in patients with gastric pain have also
shown lateralized amygdala activation in humans, with
increased neural activity observed in the right amygdala

during gastric pain [11]. In rodents, although only
scarcely reported, studies have also described lateralization of amygdala function in emotional learning and
memory processes, with the right amygdala playing a
dominant role [12-16]. These reports may be scarce
because most animal studies of amygdala function have
evaluated the two amygdalae together and as functionally
equivalent.
Anatomical studies using retrograde tracers have identified projections from the CeA to the periaqueductal gray
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(PAG) [17]. During long-term stress, increased neural
transmission has been observed in this CeA-PAG pathway
in rats [18,19]. Interestingly, consistent with our data,
these changes in neural transmission during long-term
stress occur in the right, but not the left hemisphere. It is
therefore possible that ERK activation in the right CeA
modulates pain by modulating synaptic transmission in
the CeA-PAG pathway, which might in turn feed into the
PAG-rostral ventromedial medulla-dorsal horn descending modulatory pain pathway. However, whether ERK
activation in the CeA occurs in neurons that project to the
PAG remains to be determined.
To our knowledge, this is the first study that shows a functional hemispheric lateralization of a central component
of pain processing in the amygdala of mice. Our findings
thus raise many interesting questions that are yet to be
determined: Is this hemispheric lateralization specific to
inflammatory pain or is it also seen in other types of pain?
Is this a molecular or an anatomical lateralization? What
is the mechanism underlying this lateralization? What is
the functional significance of and the anatomical explanation for this hemispheric lateralization? Although our
study does not help to clarify these issues regarding lateralization, it does provide an animal model that can be
exploited for future investigations into these questions.

Methods
Subjects
Experiments were performed in accordance with the
guidelines of the NIH and were approved by the Animal
Care and Use Committee of Washington University
School of Medicine. Male Swiss-Webster mice (40–45 g)
were housed in 12 hr light/dark cycles with food and
water provided ad libitum.
Surgical procedure
Mice were deeply anesthetized with a combination anesthetic (2.5 ml/kg body weight) consisting of Ketamine
(37.5 mg/ml), Xylazine (1.9 mg/ml), and Acepromazine
(0.37 mg/ml) and were chronically implanted with an 8
mm 26-G stainless steel guide cannula aimed at the central nucleus of the amygdala (stereotaxic coordinates
used: 1.4 mm posterior from bregma, 3.3 mm lateral to
midline, 4.2 mm ventral from skull surface). The guide
cannula was fixed to the skull using 2 jeweler's screws and
dental acrylic. An 8 mm stylet was placed in the cannula
to prevent clogging. Animals recovered for at least one
week before additional experimental procedures. At the
end of the experiment, brains were sectioned and nissl
stained to verify cannula position and injection site.
Intra-amygdala drug infusions
Microinjections were performed through a 32-G stainless
steel injection cannula that extended 0.5 mm beyond the
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tip of the guide cannula. The injection cannula was
attached to flexible plastic tubing and a microliter Hamilton syringe to perform the injections. A total volume of
0.3 μl was infused over a period of 3 min and the injection
cannula was kept in place for an additional 1 min to allow
for drug diffusion. U0126 and U0124 (VWR Scientific
Products) were dissolved in 100% DMSO to a final stock
concentration of 10 mM. On the day of the experiment,
U0126 and U0124 were diluted 1:1 in 0.9% Saline to a
concentration of 5 mM in 50% DMSO/Saline. 50%
DMSO/Saline was used as a vehicle control for all experiments. The infused volume and doses of U0126 and
U0124 were selected based on our previous biochemical
experiments that showed that inhibition of ERK activation
by U0126 under these conditions is restricted to the CeA
and that 1.5 nmoles of U0126 is the lowest dose that significantly inhibits formalin-induced ERK activation in the
CeA [4].
Nociceptive testing
Mechanical sensitivity was measured using von Frey filaments (North Coast Medical, Inc. San Jose, CA) as previously described [4]. Three to five baseline measurements
were taken from each hind-paw before formalin injection
and the average was calculated individually for each paw
as the baseline. Once the baseline was established, ten
microliters of 5% formalin solution was injected subcutaneously into the plantar surface of the right or the left
hind-paw. Intra-amygdala drug infusions were performed
2 hrs after formalin injection and mechanical hypersensitivity was measured again 1 hr after intra-amygdala drug
infusion, which corresponds to 3 hrs after formalin injection in the hindpaw. Mechanical hypersensitivity was calculated as the percentage of baseline for each hindpaw. All
behavioral testing was performed blind to pharmacological treatment.
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